BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19401691)

  • 1. TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk.
    Skoglund Lundin J; Vandrovcova J; Song B; Zhou X; Zelada-Hedman M; Werelius B; Houlston RS; Lindblom A
    Br J Cancer; 2009 May; 100(10):1674-9. PubMed ID: 19401691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer.
    Song B; Margolin S; Skoglund J; Zhou X; Rantala J; Picelli S; Werelius B; Lindblom A
    Br J Cancer; 2007 Oct; 97(8):1175-9. PubMed ID: 17848956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of polymorphisms on TGFBR1 and colorectal cancer risk: a meta-analysis.
    Zhang X; Wu L; Sheng Y; Zhou W; Huang Z; Qu J; Gao G; Cai D; Zhang M
    Mol Biol Rep; 2012 Mar; 39(3):2567-74. PubMed ID: 21858550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study.
    Castillejo A; Mata-Balaguer T; Montenegro P; Ochoa E; Lázaro R; Martínez-Cantó A; Castillejo MI; Guarinos C; Barberá VM; Guillén-Ponce C; Carrato A; Soto JL
    BMC Cancer; 2009 Jun; 9():193. PubMed ID: 19538729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: a case-control study.
    Castillejo A; Mata-Balaguer T; Guarinos C; Castillejo MI; Martínez-Cantó A; Barberá VM; Montenegro P; Ochoa E; Lázaro R; Guillén-Ponce C; Carrato A; Soto JL
    BMC Cancer; 2009 Nov; 9():406. PubMed ID: 19930569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Little evidence for association between the TGFBR1*6A variant and colorectal cancer: a family-based association study on non-syndromic family members from Australia and Spain.
    Ross JP; Lockett LJ; Tabor B; Saunders IW; Young GP; Macrae F; Blanco I; Capella G; Brown GS; Lockett TJ; Hannan GN
    BMC Cancer; 2014 Jul; 14():475. PubMed ID: 24981199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGFBR1 intralocus epistatic interaction as a risk factor for colorectal cancer.
    Martinez-Canto A; Castillejo A; Mata-Balaguer T; Castillejo MI; Hernandez-Illan E; Irles E; Barbera VM; Egoavil C; Guarinos C; Alenda C; Ochoa E; Lazaro R; Fajardo S; Lacueva J; Calpena R; Soto JL
    PLoS One; 2012; 7(1):e30812. PubMed ID: 22292045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of polymorphisms in transforming growth factor-β receptors with susceptibility to gastric cardia adenocarcinoma.
    Guo W; Dong Z; Guo Y; Chen Z; Yang Z; Kuang G
    Mol Biol Rep; 2012 Apr; 39(4):4301-9. PubMed ID: 21785915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGFBR1*6A polymorphism in sporadic and familial colorectal Carcinoma: a case-control study and systematic literature review.
    Ibrahim T; Yazbeck C; Maalouly G; Baz M; Haddad F; Sabbagh C; Chahine G
    J Gastrointest Cancer; 2014 Dec; 45(4):441-7. PubMed ID: 24880985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk.
    Skoglund J; Song B; Dalén J; Dedorson S; Edler D; Hjern F; Holm J; Lenander C; Lindforss U; Lundqvist N; Olivecrona H; Olsson L; Påhlman L; Rutegård J; Smedh K; Törnqvist A; Houlston RS; Lindblom A
    Clin Cancer Res; 2007 Jun; 13(12):3748-52. PubMed ID: 17575241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a let-7 miRNA binding region of TGFBR1 with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC).
    Xicola RM; Bontu S; Doyle BJ; Rawson J; Garre P; Lee E; de la Hoya M; Bessa X; Clofent J; Bujanda L; Balaguer F; Castellví-Bel S; Alenda C; Jover R; Ruiz-Ponte C; Syngal S; Andreu M; Carracedo A; Castells A; Newcomb PA; Lindor N; Potter JD; Baron JA; Ellis NA; Caldes T; LLor X
    Carcinogenesis; 2016 Aug; 37(8):751-8. PubMed ID: 27234654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is TGFBR1*6A a susceptibility allele for nonsyndromic familial colorectal neoplasia?
    Daley D; Morgan W; Lewis S; Willis J; Elston RC; Markowitz SD; Wiesner GL
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):892-4. PubMed ID: 17507611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between TGFBR1*6A and osteosarcoma: a Chinese case-control study.
    Hu YS; Pan Y; Li WH; Zhang Y; Li J; Ma BA
    BMC Cancer; 2010 Apr; 10():169. PubMed ID: 20429896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Int7G24A variant of transforming growth factor-beta receptor type I is associated with invasive breast cancer.
    Chen T; Jackson CR; Link A; Markey MP; Colligan BM; Douglass LE; Pemberton JO; Deddens JA; Graff JR; Carter JH
    Clin Cancer Res; 2006 Jan; 12(2):392-7. PubMed ID: 16428477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic acquisition and signaling of TGFBR1*6A in cancer.
    Pasche B; Knobloch TJ; Bian Y; Liu J; Phukan S; Rosman D; Kaklamani V; Baddi L; Siddiqui FS; Frankel W; Prior TW; Schuller DE; Agrawal A; Lang J; Dolan ME; Vokes EE; Lane WS; Huang CC; Caldes T; Di Cristofano A; Hampel H; Nilsson I; von Heijne G; Fodde R; Murty VV; de la Chapelle A; Weghorst CM
    JAMA; 2005 Oct; 294(13):1634-46. PubMed ID: 16204663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis.
    Castillejo A; Rothman N; Murta-Nascimento C; Malats N; García-Closas M; Gómez-Martínez A; Lloreta J; Tardón A; Serra C; García-Closas R; Chanock S; Silverman DT; Dosemeci M; Kogevinas M; Carrato A; Soto JL; Real FX
    Int J Cancer; 2009 Feb; 124(3):608-13. PubMed ID: 19004027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFBR1*6A may contribute to hereditary colorectal cancer.
    Bian Y; Caldes T; Wijnen J; Franken P; Vasen H; Kaklamani V; Nafa K; Peterlongo P; Ellis N; Baron JA; Burn J; Moeslein G; Morrison PJ; Chen Y; Ahsan H; Watson P; Lynch HT; de la Chapelle A; Fodde R; Pasche B
    J Clin Oncol; 2005 May; 23(13):3074-8. PubMed ID: 15860866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Int7G24A variant of transforming growth factor-beta receptor 1 is associated with osteosarcoma susceptibility in a Chinese population.
    Hu YS; Pan Y; Li WH; Zhang Y; Li J; Ma BA
    Med Oncol; 2011 Jun; 28(2):622-5. PubMed ID: 20354825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancers in patients with the (9A/6A) polymorphism of TGFBR1 exhibit lesser inter-(simple sequence repeat) PCR genomic instability and present clinically at greater age.
    Dutt SS; Chen N; Darbary HK; Swede H; Petrelli NJ; Stoler DL; Anderson GR
    Mutat Res; 2008 Oct; 645(1-2):27-32. PubMed ID: 18778720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls.
    Liao RY; Mao C; Qiu LX; Ding H; Chen Q; Pan HF
    Mol Biol Rep; 2010 Oct; 37(7):3227-32. PubMed ID: 19882361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.